Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $33,247,454.10
- Aug. 18, 2025
- Blake Borgeson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 23, 2024 | Director | 20,054 | $10.58 | Sell | $212,171.32 | |
Jan. 16, 2024 | CFO | 25,000 | $10.45 | Sell | $261,250.00 | |
Jan. 16, 2024 | Insider | 18,000 | $10.93 | Sell | $196,740.00 | |
Jan. 9, 2024 | Director | 29,000 | $13.66 | Sell | $396,140.00 | |
Jan. 3, 2024 | CEO | 30,853 | $9.49 | Sell | $292,794.97 | |
Dec. 26, 2023 | Director | 20,054 | $10.63 | Sell | $213,174.02 | |
Dec. 15, 2023 | Insider | 18,000 | $9.60 | Sell | $172,800.00 | |
Dec. 14, 2023 | Director | 20,141 | $9.00 | Sell | $181,269.00 | |
Dec. 12, 2023 | Director | 11,447 | $7.40 | Sell | $84,707.80 | |
Dec. 12, 2023 | CFO | 25,000 | $7.39 | Sell | $184,750.00 | |
Dec. 6, 2023 | CEO | 59,829 | $7.49 | Sell | $448,119.21 | |
Nov. 28, 2023 | Director | 11,447 | $6.72 | Sell | $76,923.84 | |
Nov. 16, 2023 | COO | 3,000 | $6.76 | Sell | $20,280.00 | |
Nov. 15, 2023 | Insider | 18,000 | $6.51 | Sell | $117,180.00 | |
Nov. 14, 2023 | CFO | 25,000 | $6.32 | Sell | $158,000.00 | |
Nov. 14, 2023 | Director | 8,885 | $6.32 | Sell | $56,153.20 | |
Nov. 1, 2023 | CEO | 37,177 | $5.20 | Sell | $193,320.40 | |
Oct. 31, 2023 | Director | 8,885 | $5.27 | Sell | $46,823.95 | |
Oct. 26, 2023 | COO | 3,000 | $5.63 | Sell | $16,890.00 | |
Oct. 17, 2023 | Director | 8,885 | $6.58 | Sell | $58,463.30 | |
Oct. 16, 2023 | Insider | 18,000 | $6.30 | Sell | $113,400.00 | |
Oct. 10, 2023 | CFO | 25,000 | $7.07 | Sell | $176,750.00 | |
Oct. 4, 2023 | CEO | 59,794 | $7.21 | Sell | $431,114.74 | |
Oct. 3, 2023 | Director | 8,885 | $7.29 | Sell | $64,771.65 | |
Sept. 28, 2023 | COO | 3,000 | $7.72 | Sell | $23,160.00 | |
Sept. 19, 2023 | Director | 8,885 | $8.36 | Sell | $74,278.60 | |
Sept. 15, 2023 | Insider | 18,000 | $8.66 | Sell | $155,880.00 | |
Sept. 13, 2023 | CFO | 25,000 | $8.69 | Sell | $217,250.00 | |
Sept. 6, 2023 | CEO | 33,765 | $8.78 | Sell | $296,456.70 | |
Sept. 5, 2023 | Director | 8,885 | $8.79 | Sell | $78,099.15 | |
Aug. 24, 2023 | COO | 3,000 | $8.66 | Sell | $25,980.00 | |
Aug. 22, 2023 | Director | 8,885 | $8.91 | Sell | $79,165.35 | |
Aug. 16, 2023 | CFO | 25,000 | $8.90 | Sell | $222,500.00 | |
Aug. 15, 2023 | Insider | 18,000 | $9.25 | Sell | $166,500.00 | |
Aug. 8, 2023 | Director | 17,770 | $11.16 | Sell | $198,313.20 | |
Aug. 2, 2023 | CEO | 65,015 | $13.04 | Sell | $847,795.60 | |
July 27, 2023 | COO | 8,000 | $13.62 | Sell | $108,960.00 | |
July 26, 2023 | Insider | 20,000 | $14.41 | Sell | $288,200.00 | |
July 25, 2023 | Director | 18,719 | $14.61 | Sell | $273,484.59 | |
July 18, 2023 | CFO | 25,000 | $13.63 | Sell | $340,750.00 | |
July 17, 2023 | Insider | 30,000 | $11.72 | Sell | $351,600.00 | |
July 13, 2023 | Director | 8,275 | $12.59 | Sell | $104,182.25 | |
July 12, 2023 | CEO | 31,818 | $13.14 | Sell | $418,088.52 | |
July 11, 2023 | Director | 8,885 | $6.89 | Sell | $61,217.65 | |
June 29, 2023 | COO | 3,000 | $7.49 | Sell | $22,470.00 | |
June 27, 2023 | Director | 8,885 | $7.39 | Sell | $65,660.15 | |
June 13, 2023 | CFO | 25,000 | $9.93 | Sell | $248,250.00 | |
June 13, 2023 | Director | 15,485 | $9.98 | Sell | $154,540.30 | |
June 7, 2023 | CEO | 56,436 | $9.05 | Sell | $510,745.80 | |
June 1, 2023 | Insider | 25,000 | $8.58 | Sell | $214,500.00 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Michael Secora, Shafique Virani, Tina Marriott, Mubadala Investment Co Pjsc, Dean Y Li, Gibson Christopher, Zavain Dar, Najat Khan, and Terry-Ann Burrell
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 53 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Aug. 18, 2025.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.